Proteasome activators

Tormentilla, St. juniper, and Hamamelis extracts enhance proteasome activity, addressing aging-related protein accumulation and immune decline, thereby improving skin health and function.

JP7589988B2Active Publication Date: 2024-11-26ICHIMARU PHARCOS CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2021024746
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-02-25
Filing Date
2021-02-19
Publication Date
2024-11-26
Estimated Expiration
2041-02-19

AI Technical Summary

Technical Problem

Existing technologies do not effectively address the decline in proteasome activity with age, leading to protein accumulation and reduced immune function, which contributes to aging and skin dullness.

Method used

Development of proteasome activators using extracts from Tormentilla, St. juniper, and Hamamelis to enhance intracellular proteasome activity.

Benefits of technology

Activates proteasomes in human cells, reducing protein accumulation, improving skin elasticity, and enhancing immune function by promoting the degradation of malfunctioning and foreign proteins.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007589988000001
    Figure 0007589988000001
  • Figure 0007589988000002
    Figure 0007589988000002
  • Figure 0007589988000003
    Figure 0007589988000003
Patent Text Reader

Abstract

To provide a composition for inducing the activation of proteasome in a cell.SOLUTION: The inventors have conducted intense study to search for a substance having the action of activating proteasome, leading to discover that extract from Potentilla tormentilla, Juniperus communis, and Hamamelis virginiana have the activating action, completing the composition.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Method for discriminating ageing-improving agent and skin lotion containing ageing-improving agent

    JP2001131044A

  • Elastase activity inhibitor

    JP2003183171A

  • SCF expression inhibitor

    JP2006176436A

  • Kinesin inhibitor

    JP2013166713A

  • Skin darkening inhibitor, cosmetics and skin external preparation

    JP2018203725A